Neurocognitive Assessment and Rehabilitation Market By Assessment Type (Cognitive Screening Tests, Behavioural Assessment, Functional Assessment), By Rehabilitation Type (Cognitive Training Software, Speech & Language Therapy, Occupational Therapy, Physical Therapy), By Application (Dementia & Alzheimer’s Disease, Traumatic Brain Injury (TBI), Stroke Rehabilitation, ADHD & Learning Disabilities, Multiple Sclerosis, Clinical Evaluation, Educational Settings, Research Development), By End-user (Hospitals & Clinics, Research & Academic Institutes, Rehabilitation Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Neurocognitive Assessment and Rehabilitation Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising Neurological Disorder Prevalence Is Increasing the Need for Advanced Neurocognitive Assessment Technologies

3.2.2. Advancements in Artificial Intelligence and Machine Learning Are Transforming Cognitive Rehabilitation Solutions

3.2.3. Growing Public Awareness and Early Diagnosis Initiatives Are Driving Adoption of Neurocognitive Assessment Solutions

3.3. Key industry pitfalls & challenges

3.3.1. Limited Access to Neurocognitive Rehabilitation Services Due to High Costs and Unequal Healthcare Infrastructure

3.3.2. Ethical and Data Privacy Concerns in AI-Based Neurocognitive Assessment Tools Could Hinder Market Growth

3.3.3. Challenges in Standardizing Cognitive Assessment Protocols Across Global Healthcare Systems Limit Market Expansion

3.4. Market Opportunities

3.4.1. Integration of Virtual Reality (VR) and Augmented Reality (AR) to Enhance Cognitive Rehabilitation Outcomes

3.4.2. Expansion of Telehealth and Digital Therapeutics for Remote Neurocognitive Assessment and Therapy

3.4.3. Increasing Collaborations Between Tech Companies and Healthcare Providers Are Accelerating Innovation in Neurocognitive Rehabilitation

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Neurocognitive Assessment and Rehabilitation Market, Assessment Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Assessment Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Cognitive Screening Tests

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Behavioural Assessment

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Functional Assessment

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Neurocognitive Assessment and Rehabilitation Market, Rehabilitation Type Segment Analysis

5.1. Overview Dynamics

5.1.1. Market Revenue Share, By Rehabilitation Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Cognitive Training Software

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Speech & Language Therapy

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Occupational Therapy

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Physical Therapy

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Neurocognitive Assessment and Rehabilitation Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Dementia & Alzheimer’s Disease

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Traumatic Brain Injury (TBI)

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Stroke Rehabilitation

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. ADHD & Learning Disabilities

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Multiple Sclerosis

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Clinical Evaluation

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.8. Educational Settings

6.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.9. Research Development

6.9.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Neurocognitive Assessment and Rehabilitation Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals & Clinics

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Research & Academic Institutes

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Rehabilitation Centers

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Neurocognitive Assessment and Rehabilitation Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Assessment Type, 2025-2035

8.2.3. North America Market Revenue, By Rehabilitation Type, 2025-2035

8.2.4. North America Market Revenue, By Application, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Assessment Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Rehabilitation Type, 2025-2035

8.2.6.3. U.S. Market Revenue, By Application, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Assessment Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Rehabilitation Type, 2025-2035

8.2.7.3. Canada Market Revenue, By Application, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Assessment Type, 2025-2035

8.3.3. Europe Market Revenue, By Rehabilitation Type, 2025-2035

8.3.4. Europe Market Revenue, By Application, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Assessment Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Rehabilitation Type, 2025-2035

8.3.6.3. Germany Market Revenue, By Application, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Assessment Type, 2025-2035

8.3.7.2. France Market Revenue, By Rehabilitation Type, 2025-2035

8.3.7.3. France Market Revenue, By Application, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Assessment Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Rehabilitation Type, 2025-2035

8.3.8.3. U.K. Market Revenue, By Application, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Assessment Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Rehabilitation Type, 2025-2035

8.3.9.3. Italy Market Revenue, By Application, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Assessment Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Rehabilitation Type, 2025-2035

8.3.10.3. Spain Market Revenue, By Application, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Assessment Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Rehabilitation Type, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Assessment Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Rehabilitation Type, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Assessment Type, 2025-2035

8.4.6.2. China Market Revenue, By Rehabilitation Type, 2025-2035

8.4.6.3. China Market Revenue, By Application, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Assessment Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Rehabilitation Type, 2025-2035

8.4.7.3. Japan Market Revenue, By Application, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Assessment Type, 2025-2035

8.4.8.2. India Market Revenue, By Rehabilitation Type, 2025-2035

8.4.8.3. India Market Revenue, By Application, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Assessment Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Rehabilitation Type, 2025-2035

8.4.9.3. Australia Market Revenue, By Application, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Assessment Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Rehabilitation Type, 2025-2035

8.4.10.3. South Korea Market Revenue, By Application, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Assessment Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Rehabilitation Type, 2025-2035

8.4.11.3. Singapore Market Revenue, By Application, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Assessment Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Rehabilitation Type, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Assessment Type, 2025-2035

8.5.3. Latin America Market Revenue, By Rehabilitation Type, 2025-2035

8.5.4. Latin America Market Revenue, By Application, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Assessment Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Rehabilitation Type, 2025-2035

8.5.6.3. Brazil Market Revenue, By Application, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Assessment Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Rehabilitation Type, 2025-2035

8.5.7.3. Argentina Market Revenue, By Application, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Assessment Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Rehabilitation Type, 2025-2035

8.5.8.3. Mexico Market Revenue, By Application, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Assessment Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Rehabilitation Type, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Assessment Type, 2025-2035

8.6.3. MEA Market Revenue, By Rehabilitation Type, 2025-2035

8.6.4. MEA Market Revenue, By Application, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Assessment Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Rehabilitation Type, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Assessment Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Rehabilitation Type, 2025-2035

8.6.7.3. South Africa Market Revenue, By Application, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Assessment Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Rehabilitation Type, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Pearson Assessments

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Cambridge Cognition, Ltd

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Cogstate Ltd.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Posit Science

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. CNS Vital Signs, LLC

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Lumos Labs, Inc.

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. NeuroNation

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. HappyNeuron

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Emotiv

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. NeuroSky

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. BrainTrain, Inc.

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Creyos Health

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. NovaVision, LLC

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. HASOMED GmbH

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Medtronic

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis

9.16. Abbott

9.16.1. Business Overview

9.16.2. Financial Performance

9.16.3. Product/Service Offerings

9.16.4. Strategies & recent developments

9.16.5. SWOT Analysis

9.17. BrainCheck

9.17.1. Business Overview

9.17.2. Financial Performance

9.17.3. Product/Service Offerings

9.17.4. Strategies & recent developments

9.17.5. SWOT Analysis

9.18. Constant Therapy

9.18.1. Business Overview

9.18.2. Financial Performance

9.18.3. Product/Service Offerings

9.18.4. Strategies & recent developments

9.18.5. SWOT Analysis

9.19. Thought Technology Ltd.

9.19.1. Business Overview

9.19.2. Financial Performance

9.19.3. Product/Service Offerings

9.19.4. Strategies & recent developments

9.19.5. SWOT Analysis